Interstitial photodynamic therapy and glioblastoma: Light fractionation in a preclinical model
- 24 December 2016
- journal article
- case report
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 49 (5) , 506-515
Abstract
Background Glioblastoma is a high‐grade cerebral tumor with local recurrence and poor outcome. Photodynamic therapy (PDT) is a localized treatment based on the light activation of a photosensitizer (PS) in the presence of oxygen, which results in the formation of cytotoxic species. The delivery of fractionated light may enhance treatment efficacy by reoxygenating tissues. Objective To evaluate the efficiency of two light‐fractionation schemes using immunohistological data. Materials and Methods Human U87 cells were grafted into the right putamen of 39 nude rats. After PS precursor intake (5‐ALA), an optic fiber was introduced into the tumor. The rats were randomly divided into three groups: without light, with light split into 2 fractions and with light split into 5 fractions. Treatment effects were assessed using brain immunohistology. Results Fractionated treatments induced intratumoral necrosis (P < 0.001) and peritumoral edema (P = 0.009) associated with a macrophagic infiltration (P = 0.006). The ratio of apoptotic cells was higher in the 5‐fraction group than in either the sham (P = 0.024) or 2‐fraction group (P = 0.01). Peripheral vascularization increased after treatment (P = 0.017), and these likely new vessels were more frequently observed in the 5‐fraction group (P = 0.028). Conclusion Interstitial PDT with fractionated light resulted in specific tumoral lesions. The 5‐fraction scheme induced more apoptosis but led to greater peripheral neovascularization. Lasers Surg. Med. 49:506–515, 2017.Keywords
This publication has 38 references indexed in Scilit:
- 5-ALA-PDT induces RIP3-dependent necrosis in glioblastomaPhotochemical & Photobiological Sciences, 2011
- Heat-shock protein 70-dependent dendritic cell activation by 5-aminolevulinic acid-mediated photodynamic treatment of human glioblastoma spheroids in vitroBritish Journal of Cancer, 2011
- Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection studyJournal of Neurosurgery, 2011
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007
- 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cellsNeuroscience Letters, 2007
- Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acidJournal of Neurosurgery, 2002
- Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colonJournal of Photochemistry and Photobiology B: Biology, 2000
- Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat ColonPhotochemistry and Photobiology, 1999
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- DEPTH MEASUREMENTS AND HISTOPATHOLOGICAL CHARACTERIZATION OF PHOTODYNAMIC THERAPY GENERATED NORMAL BRAIN NECROSIS AS A FUNCTION OF INCIDENT OPTICAL ENERGY DOSEPhotochemistry and Photobiology, 1991